メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
藤田医科大学でコンテンツを検索
ホーム
プロファイル
研究部門
研究成果
第４・婦人科
病院局
岡崎医療センター
概要
フィンガープリント
研究成果
(21)
フィンガープリント
第４・婦人科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Undifferentiated Carcinoma
100%
Carcinoma Cell Lines
100%
Carcinogenicity
100%
Spinal Epidural Hematoma
100%
Endometrium
100%
Endometrial Carcinoma
100%
Cystic Teratoma
100%
Ectopic Ovary
100%
Fallopian Tube
100%
Management Outcome
100%
Primordial Follicle
100%
Laparoscopy
100%
Model Comparison
100%
Laparoscopic Management
100%
Androgen-producing Tumor
100%
Venous Catheterization
100%
Past Users
75%
HMSH2
66%
Hyperplasia
66%
Microvascular Invasion
66%
Microsatellite Instability-high (MSI-H)
66%
No Significant Difference
66%
Endometrioid
66%
TP53 mutation
66%
Histological Subtypes
66%
Lymph Node Metastasis
66%
KRAS mutation
66%
HMLH1
66%
Ultrasonically Activated Scalpel
60%
Electrothermal Bipolar Vessel Sealer
60%
Ovulation Induction
60%
Monopolar Electrocautery
60%
Loop Type
60%
Tumor
53%
Vaginal Carcinoma
50%
Intratumoral Administration
50%
Immunologic Therapy
50%
Wolffian Duct
50%
Gonadal Ridge
50%
Right Ovary
50%
Left Ovary
50%
Fimbriae
50%
Normal Position
50%
Dermoid Cyst
50%
Hyperandrogenism
50%
Doppler Ultrasound
50%
Hirsutism
50%
L-cells
40%
Cyclic Therapy
40%
Endometrioid Carcinoma
33%
Biological Characteristics
33%
Endometrioid Adenocarcinoma
33%
Mechanisms of Carcinogenesis
33%
Protein Expression
33%
Stage III-IV
33%
Vascular Hemodynamics
33%
Progressive Paralysis
33%
Clear Cell Type
33%
Serous
33%
FIGO Stage
33%
P53 Expression
33%
Immunohistochemistry
33%
Worse Prognosis
33%
Type II Endometrial Carcinoma
33%
CD4 Positive Cells
33%
Ovulatory
25%
Wave Flow
25%
Tortuous Vessel
25%
Gynecologist
25%
Flow Index
25%
Uterine Doppler
25%
Obstetricians
25%
Androstendione
25%
Modern Imaging
25%
Pelvic Ultrasound
25%
Vascular Channels
25%
Low Impedance
25%
Grayscale Ultrasonography
25%
Ultrasonic Resonance
25%
Uterine Vessels
25%
Uterine Artery
25%
Uterine Wall
25%
Magnetic Resonance (MR) Angiography
25%
Number of Pregnancies
25%
Transvaginal Ultrasound
25%
Tumor Removal
25%
Leydig Cell Tumor
25%
Secondary Amenorrhea
25%
Abdominal Ultrasound
25%
In Vitro Fertilization
25%
Loss of Expression
20%
Chromosomal Microarray
20%
New Cell Line
20%
Spindle-shaped
20%
Doubling Time
20%
Primary Tumor
20%
Aneuploidy
20%
Hormonal Treatment
20%
Older Patients
20%
E-cadherin
20%
Medicine and Dentistry
Anaplastic Carcinoma
100%
Tamoxifen
100%
Endometrium Carcinoma
100%
Carcinoma Cell Line
100%
Carcinogenicity
100%
Spinal Hematoma
100%
Endometrium
100%
Schizophyllan
100%
Surgery
100%
Laparoscopy
100%
Primordial Follicle
100%
Fallopian Tube
100%
Uterus Horn
100%
Tissue Adhesion
100%
Vein Catheterization
100%
Protein P53
75%
Lymph Node Metastasis
70%
Doppler Flowmetry
66%
Cell Line
60%
Fulguration
60%
Tuberous Sclerosis
60%
Hyperplasia
50%
Microsatellite Instability
50%
Ras Signaling
50%
Wolffian Duct
50%
Fimbria
50%
Hyperandrogenism
50%
Hirsutism
50%
Neoplasm
45%
Ovulation Induction
40%
Gray Scale Echography
33%
Uterine Artery
33%
Adenocarcinoma
25%
Endometrioid Carcinoma
25%
Clear Cell
25%
Protein Expression
25%
Carcinogenesis
25%
Immunohistochemistry
25%
Secondary Amenorrhea
25%
Leydig Cell Tumour
25%
Alpha Catenin
20%
SCID Mouse
20%
Primary Tumor
20%
Cell Contact
20%
Uvomorulin
20%
Gestagen
20%
Progesterone Derivative
20%
Endometrial Biopsy
20%
In Vitro
20%
Chromosome Analysis
20%
Aneuploidy
20%
Aggression
20%
Adhesive Agent
20%
Pneumoperitoneum
20%
General Anesthesia
20%
Kruskal Wallis Test
20%
Laparotomy
20%
Salpingooophorectomy
20%
Laparoscopic Surgery
20%
Ovulation
20%
Gonadorelin Agonist
20%
Lymph Node Biopsy
20%
Human Menopausal Gonadotropin
20%
Surgical Instrument
20%
Endometrial Polyp
12%
Endometrial Cancer Cell Line
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclooxygenase 2
100%
Endometrium Cancer
100%
Neoplasm
100%
COX-2 Inhibitor
100%
Vagina Cancer
100%
Schizophyllan
100%
Leukotriene B4
100%
Premature Ovarian Failure
100%
Etodolac
54%
Vagina Carcinoma
33%
Human Menopausal Gonadotropin
33%
Chorionic Gonadotropin
33%
Gonadorelin Agonist
33%
Arteriovenous Malformation
33%
Dysmenorrhea
33%
Pneumoperitoneum
20%
Telomerase
18%
Endometrium Polyp
12%
Female Genital Tract Cancer
9%
Fibroblast Growth Factor 2
9%
Disease Free Survival
9%
Survival Rate
9%
Chemopreventive Agents
9%
Angiogenic Factor
9%
Protein P53
9%
Malignant Neoplasm
9%